Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Muggia

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Investigational New Drugs|July 1, 2009
Phase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles Henderson, Lynn Feun, et al.
Breast Cancer Research and Treatment|November 11, 2017
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancerMaryann Kwa, Xiaochun Li, Yelena Novik, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 22, 2014
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancerTimothy M Zagar, Zeljko Vujaskovic, Silvia Formenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
ACCO: ASCO core curriculum outlineHyman B Muss, Jamie Von Roenn, Lloyd Earl Damon, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Investigational New Drugs|July 1, 2009
Phase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles Henderson, Lynn Feun, et al.
Breast Cancer Research and Treatment|November 11, 2017
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancerMaryann Kwa, Xiaochun Li, Yelena Novik, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 22, 2014
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancerTimothy M Zagar, Zeljko Vujaskovic, Silvia Formenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
ACCO: ASCO core curriculum outlineHyman B Muss, Jamie Von Roenn, Lloyd Earl Damon, et al.
Pageof 10